Adage Capital Partners’s AC Immune ACIU Stock Holding History

Adage Capital Partners’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-100,000	Closed	-$1.65M	–	682
2016 Q3	$1.65M	Buy	+100,000	New	+$1.73M	﹤0.01%	652

Other funds holding ACIU

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 21.71% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Adage Capital Partners's ACIU Position: Q4 2016 in Review

Adage Capital Partners sold out of AC Immune (ACIU) in Q4 2016, closing a stake of 100,000 shares — an estimated $1.65M sold.

Adage Capital Partners first reported a position in ACIU in Q3 2016 and held it in 1 quarter. The position peaked at $1.65M in Q3 2016. 19 funds tracked by Wall St. Rank hold ACIU as of Q4 2016.

Adage Capital Partners reported no remaining AC Immune position as of Q4 2016 after selling out during the quarter.
Adage Capital Partners sold 100,000 AC Immune shares in Q4 2016, an estimated $1.65M.
Adage Capital Partners first reported a position in AC Immune in Q3 2016 and held it in 1 quarter.
Adage Capital Partners's AC Immune position peaked at $1.65M in Q3 2016.
19 funds tracked by Wall St. Rank held AC Immune as of Q4 2016.

Based on Adage Capital Partners's 13F filing for Q4 2016, filed 14 Feb 2017.